Models and Mechanisms of Fibrosis Resolution

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 5, 2011, Pages 794-799

  Snowdon, Victoria K ^a   Fallowfield, Jonathan A ^b  

^a NORTH DEVON DISTRICT HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Hepatic stellate cell; Liver fibrosis; Matrix metalloproteinases; Tissue inhibitors of metalloproteinases

Indexed keywords

ALCOHOL; CARBON TETRACHLORIDE; CHOLINE; DIMETHYLNITROSAMINE; MATRIX METALLOPROTEINASE; METHIONINE; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BILE DUCT LIGATION; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; KNOCKOUT MOUSE; LIVER BIOPSY; LIVER CARCINOMA; LIVER CELL; LIVER FIBROSIS; LIVER TOXICITY; MODEL; MOUSE; NONHUMAN; NUTRITIONAL DEFICIENCY; PORTAL HYPERTENSION; PRIORITY JOURNAL; SCAR FORMATION; STELLATE CELL; TRANSGENIC MOUSE; WOUND HEALING;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; LIVER CIRRHOSIS; LIVER REGENERATION;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 79955484151     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01400.x     Document Type: Conference Paper

References (58)

1. Anstee QM, Goldin RD (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87:1-16.
2. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209-231.
3. Benyon RC, Hovell CJ, Gaça M, Jones EH, Iredale JP, Arthur MJ (1999) Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology 30:977-986.
4. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJP (1996) Increased expression of tissue inhibitor of metalloproteinases-1 and -2 relative to interstitial collagenase in fibrotic human liver. Gastroenterology 110:821-831.
5. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T (2002) Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 36:200-209.
6. Constandinou C, Henderson N, Iredale JP (2005) Modelling liver fibrosis in rodents. Methods Mol Med 117:237-250.
7. Desmet VJ, Roskams T (2004) Cirrhosis reversal: a duel between dogma and myth. J Hepatol 40:860-867.
8. Dienstag JL, Goldin RD, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, Gardner S, Gray DF, Schiff ER (2003) Histological outcome during long-term lamivudine therapy. Gastroenterology 124:105-117.
9. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP (2005) Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115:56-65.
10. Dufour JF, DeLellis R, Kaplan MM (1997) Reversibility of hepatic fibrosis is autoimmune hepatitis. Ann Intern Med 127:981-985.
11. Elsharkawy AM, Oakley F, Mann DA (2005) The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10:927-939.
12. Fallowfield JA, Iredale JP (2004) Targeted treatments for cirrhosis. Expert Opin Ther Targets 8:423-435.
13. Fallowfield JA, Kendall TJ, Iredale JP (2006) Reversal of liver fibrosis: not just a pipe dream. Clin Liv Dis 10:481-497.
14. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, Iredale JP (2007) Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 178:5288-5295.
15. Fernandez M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J (2009) Angiogenesis in liver disease. J Hepatol 50:604-620.
16. Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA, Alison MR (2004) A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126:955-963.
17. Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247-2250.
18. Friedman SL (2003) Liver fibrosis-from bench to bedside. J Hepatol 38(S1):S38-S53.
19. Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655-1669.
20. Friedman SL, Roll FJ, Boyles J, Bissell DM (1985) Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 82:8681-8685.
21. Gaca MD, Zhou X, Issa R, Kiriella K, Iredale JP, Benyon RC (2003) Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol 22:229-239.
22. Geerts A (2001) History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 21:311-335.
23. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7:793-807.
24. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Fléjou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P, Lévy P (2001) Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344:418-423.
25. Henderson NC, Forbes SJ (2008) Hepatic fibrogenesis: from within and outwith. Toxicology 254(3):130-5.
26. Huang H, Shiffman ML, Cheung RC, Layden TJ, Friedman S, Abar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J, Catanese JJ, Leong DU, Ross D, Hu X, Monto A, McAllister LB, Broder S, White T, Sninsky JJ, Wright TL (2006) Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology 130(6):1679-1687.
27. Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H (2005) Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 128:138-146.
28. Iredale JP (2001) Hepatic stellate cell behaviour during resolution of liver fibrosis. Semin Liver Dis 21:427-436.
29. Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539-548.
30. Iredale JP, Benyon RC, Arthur MJP, Ferris WF, Alcolado R, Winwood PJ, Clark N, Murphy G (1996) TIMP-1 and interstitial collagenase expression in liver fibrosis; implications for pathogenesis. Hepatology 24:176-184.
31. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop S, Pawley S, Hovell CJ, Arthur MJP (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102:538-549.
32. Issa R, Williams E, Trim N, Kendall T, Arthur MJ, Reichen J, Benyon RC, Iredale JP (2001) Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 48:548-557.
33. Issa R, Xhou X, Trim N, Millward-Sadler H, Krane S, Benyon RC, Iredale JP (2003) Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistance of activated hepatic stellate cells and diminished hepatocyte regeneration. FASEB J 17:47-49.
34. Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MD, Sands E, Suliman I, Trim N, Knorr A, Arthur MJP, Benyon RC, Iredale JP (2004) Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126:1795-1808.
35. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Kalluri R, Neilson EG (2003) Epithelial mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784.
36. Kisseleva T, Brenner DA (2007) Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 22(S1):S73-S78.
37. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, Brenner DA (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45:429-438.
38. Knittel T, Dinter C, Kobold D, Neubauer K, Mehde M, Eichhorst S, Ramadori G (1999) Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol 154:153-167.
39. Leon DA, McCambridge J (2006) Liver cirrhosis mortality rates in Britain, 1950-2002. Lancet 367:645.
40. Luedde T, Trautwein C, Tacke F (2009) Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50(1):261-274.
41. Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G (2006) Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol 44:111-117.
42. Okazaki I, Maruyama K (1974) Collagenase activity in experimental hepatic fibrosis. Nature 252:49-50.
43. Parsons CJ, Bradford BU, Pan CQ, Cheung E, Schauer M, Knorr A, Krebs B, Kraft S, Zahn S, Brocks B, Feirt N, Mei B, Cho MS, Ramamoorthi R, Roldan G, Ng P, Lum P, Hirth-Dietrich C, Tomkinson A, Brenner DA (2004) Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology 40:1106-1115.
44. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE (1989) Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat storing cells. J Clin Invest 84:1786-1793.
45. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, Ling MH, Albrecht J (2002) Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122:1303-1313.
46. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J (2001) Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34(5):730-739.
47. Roderfeld M, Weiskirchen R, Wagner S, Berres ML, Henkel C, Grötzinger J, Gressner AM, Matern S, Roeb E (2006) Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice. FASEB J 20:444-454.
48. Roeb E, Behrmann I, Grotzinger J, Breuer B, Matern S (2000) An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1 antagonist. FASEB J 14:1671-1673.
49. Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F, Bou-Gharios G, Jeffery R, Iredale JP, Forbes SJ (2006) The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130:1807-1821.
50. Schuppan D, Ruehl M, Sonasundaram R, Hahn EG (2001) Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 21:351-372.
51. Siller-Lopex F, Sandoval A, Salgado S, Salazar A, Bueno M, Garcia J, Vera J, Gálvez J, Hernández I, Ramos M, Aguilar-Cordova E, Armendariz-Borunda J (2004) Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology 126:1122-1133.
52. Tsukamoto H, Matsuoka M, French SW (1990) Experimental models of hepatic fibrosis: a review. Semin Liver Dis 10:56-65.
53. Vinas O, Bataller R, Sancho-Bru P, Ginès P, Berenguer C, Enrich C, Nicolás JM, Ercilla G, Gallart T, Vives J, Arroyo V, Rodés J (2003) Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 38:919-929.
54. Wanless IR, Nakashima E, Sherman M (2000) Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 124:1599-1607.
55. Wells RG (2005) The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. J Clin Gastroenterol 39(S2):S158-S161.
56. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H (2000) Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32:1248-1254.
57. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Fukui H (2002) Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36:850-860.
58. Zhou X, Hovell CJ, Pawley S, Hutchings MI, Arthur MJ, Iredale JP, Benyon RC (2004) Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int 24:492-501.